Article citationsMore >>

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Marc GP, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020; 383: 2603-15.

has been cited by the following article:

Article

Recurrent mRNA (BNT162b2) Covid-19 Vaccine-Associated Pericarditis in an Elderly Man with Multiple Comorbidities

1Department of Internal Medicine, Griffin Hospital, Derby, CT

2Department of Cardiology, Griffin Hospital, Derby, CT


American Journal of Medical Case Reports. 2021, Vol. 9 No. 12, 709-713
DOI: 10.12691/ajmcr-9-12-12
Copyright © 2021 Science and Education Publishing

Cite this paper:
Angel Goenawan, Frank Kussaga, Kenneth Schwartz, Seema D’Souza. Recurrent mRNA (BNT162b2) Covid-19 Vaccine-Associated Pericarditis in an Elderly Man with Multiple Comorbidities. American Journal of Medical Case Reports. 2021; 9(12):709-713. doi: 10.12691/ajmcr-9-12-12.

Correspondence to: Angel  Goenawan, Department of Internal Medicine, Griffin Hospital, Derby, CT. Email: angel.goenawan@gmail.com

Abstract

Myocarditis and pericarditis are known adverse effects from mRNA Covid-19 vaccines and are seen in young men usually after the second dose of vaccine. We report a case of recurrent pericarditis in a 67 year old man with history of diabetes and chronic kidney disease that occured with both vaccine doses, with the second episode associated with interval development of small pericardial effusion and moderate pleural effusion. Patient did not seem to have concomitant myocarditis as he did not have any troponin leak. He was managed with colchicine and prednisone with resultant improvement of his inflammatory markers on follow up.

Keywords